• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过改变HLA I类分子的O-糖基化来逃避CTL免疫的机制。

A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.

作者信息

Sutoh Yoneyama Mihoko, Tobisawa Yuki, Hatakeyama Shingo, Sato Misaki, Tone Kiyoshi, Tatara Yota, Kakizaki Ikuko, Funyu Tomihisa, Fukuda Minoru, Hoshi Senji, Ohyama Chikara, Tsuboi Shigeru

机构信息

Department of Cancer Immunology and Cell Biology, Oyokyo Kidney Research Institute, Hirosaki, Japan.

Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

出版信息

J Biochem. 2017 Jun 1;161(6):479-492. doi: 10.1093/jb/mvw096.

DOI:10.1093/jb/mvw096
PMID:28011817
Abstract

Anti-tumour immunity by cytotoxic T-lymphocytes (CTLs) is essential to suppress tumour progression. Cancer cells that evade CTL immunity proliferate in the host, promoting metastasis, but mechanisms underlying this capacity remain unknown. Here we report that bladder cancer cells metastasized to lymph nodes evade CTL immunity by a new mechanism via altered glycosylation. CTLs normally recognize and kill cancer cells presenting antigenic peptides on human leukocyte antigen (HLA) class I. We show bladder cancer cells expressing the O-glycan processing enzyme, core2 β-1,6-N-acetylglucosaminyltransferase (C2GnT) exhibit HLA class I O-glycan modified with poly-N-acetyllactosamine and are highly susceptible to CTL. In those cells, poly-N-acetyllactosamine on HLA class I O-glycan binds galectin-3 to form a cell-surface molecular lattice, enabling efficient cell-surface retention of HLA class I. In contrast, bladder cancer cells in which C2GnT is downregulated show decreased levels of poly-N-acetyllactosamine on HLA class I O-glycans, attenuating lattice formation and reducing the cell-surface half-life of HLA class I. These tumour cells present antigenic peptides less efficiently, thereby evading CTL lysis and facilitating metastasis.

摘要

细胞毒性T淋巴细胞(CTL)介导的抗肿瘤免疫对于抑制肿瘤进展至关重要。逃避CTL免疫的癌细胞在宿主体内增殖,促进转移,但其潜在机制尚不清楚。在这里,我们报告膀胱癌细胞转移至淋巴结后通过一种新的机制——糖基化改变来逃避CTL免疫。CTL通常识别并杀死在人类白细胞抗原(HLA)I类分子上呈递抗原肽的癌细胞。我们发现,表达O-聚糖加工酶核心2β-1,6-N-乙酰葡糖胺基转移酶(C2GnT)的膀胱癌细胞,其HLA I类分子的O-聚糖被多聚N-乙酰乳糖胺修饰,且对CTL高度敏感。在这些细胞中,HLA I类分子O-聚糖上的多聚N-乙酰乳糖胺与半乳糖凝集素-3结合形成细胞表面分子晶格,从而使HLA I类分子有效地保留在细胞表面。相反,C2GnT表达下调的膀胱癌细胞,其HLA I类分子O-聚糖上的多聚N-乙酰乳糖胺水平降低,晶格形成减弱,HLA I类分子在细胞表面的半衰期缩短。这些肿瘤细胞呈递抗原肽的效率降低,从而逃避CTL裂解并促进转移。

相似文献

1
A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.通过改变HLA I类分子的O-糖基化来逃避CTL免疫的机制。
J Biochem. 2017 Jun 1;161(6):479-492. doi: 10.1093/jb/mvw096.
2
Implications of altered O-glycosylation in tumour immune evasion.糖基化修饰改变在肿瘤免疫逃逸中的意义。
J Biochem. 2019 May 1;165(5):387-390. doi: 10.1093/jb/mvz003.
3
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.肿瘤通过表达核心 2 O-聚糖逃避 NK 细胞免疫的新策略。
EMBO J. 2011 Jun 28;30(15):3173-85. doi: 10.1038/emboj.2011.215.
4
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.MUC1 携带核心 2 O-聚糖可作为分子盾牌,防止 NK 细胞攻击,从而促进膀胱癌转移。
Int J Oncol. 2012 Jun;40(6):1831-8. doi: 10.3892/ijo.2012.1411. Epub 2012 Mar 23.
5
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.核心 2 O-聚糖表达的前列腺癌细胞对 NK 细胞免疫具有抗性。
Mol Med Rep. 2013 Feb;7(2):359-64. doi: 10.3892/mmr.2012.1189. Epub 2012 Nov 19.
6
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.膀胱癌中的肿瘤逃逸表型与 HLA Ⅰ类分子表达缺失、T 细胞排除和基质改变有关。
Int J Mol Sci. 2021 Jul 6;22(14):7248. doi: 10.3390/ijms22147248.
7
Involvement of HLA class I molecules in the immune escape of urologic tumors.HLA I类分子在泌尿系统肿瘤免疫逃逸中的作用
Actas Urol Esp. 2014 Apr;38(3):192-9. doi: 10.1016/j.acuro.2013.06.006. Epub 2013 Dec 7.
8
Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.致癌转化细胞中MHC I类抗原的抑制:与细胞毒性T淋巴细胞识别能力降低相关
Exp Hematol. 1996 Sep;24(11):1275-9.
9
Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.通过工程化抗原呈递细胞将天然TROP-2肿瘤抗原呈递给人细胞毒性T淋巴细胞。
Int J Cancer. 2002 Oct 1;101(4):353-9. doi: 10.1002/ijc.10616.
10
TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.转化生长因子-β(TGF-β)和表皮生长因子(EGF)诱导的HLA-I下调与前列腺癌细胞中通过上调蜗牛蛋白(Snail)的上皮-间质转化(EMT)相关。
Mol Immunol. 2015 May;65(1):34-42. doi: 10.1016/j.molimm.2014.12.017. Epub 2015 Jan 22.

引用本文的文献

1
Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity.糖基化作为一个复杂的翻译后修饰过程,参与了与糖蛋白相关的免疫反应。
Cell Commun Signal. 2025 May 5;23(1):214. doi: 10.1186/s12964-025-02216-w.
2
Low GCNT2/I-Branching Glycan Expression Is Associated with Bladder Cancer Aggressiveness.低GCNT2/I-分支聚糖表达与膀胱癌侵袭性相关。
Biomedicines. 2025 Mar 10;13(3):682. doi: 10.3390/biomedicines13030682.
3
CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription.
CCDC88C是GALNT6的O-连接N-乙酰半乳糖胺糖基化底物,通过促进c-JUN介导的CEMIP转录来驱动乳腺癌转移。
Cancer Cell Int. 2024 Jul 6;24(1):237. doi: 10.1186/s12935-024-03413-2.
4
Altered Glycosylation in Progression and Management of Bladder Cancer.膀胱癌进展和管理中的糖基化改变。
Molecules. 2023 Apr 13;28(8):3436. doi: 10.3390/molecules28083436.
5
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines.细胞表面HLA I类分子的四种形式:其抗原性和免疫原性差异为疫苗创造新靶点
Vaccines (Basel). 2022 Feb 21;10(2):339. doi: 10.3390/vaccines10020339.
6
Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity.核心2 β1,6-N-乙酰葡糖胺基转移酶加速绒毛膜癌逃避自然杀伤细胞免疫。
Biochem Biophys Rep. 2021 Feb 13;26:100951. doi: 10.1016/j.bbrep.2021.100951. eCollection 2021 Jul.
7
Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer.O-连接的N-乙酰葡糖胺糖基化修饰在结直肠癌发生、发展及治疗中的研究进展
World J Gastrointest Surg. 2021 Feb 27;13(2):96-115. doi: 10.4240/wjgs.v13.i2.96.
8
Tumor vasculature-targeted B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.通过与膜联蛋白 A1 结合的肽进行肿瘤血管靶向 B 递送来增强硼中子俘获治疗的效果。
BMC Cancer. 2021 Jan 15;21(1):72. doi: 10.1186/s12885-020-07760-x.
9
The Roles of Glycans in Bladder Cancer.聚糖在膀胱癌中的作用。
Front Oncol. 2020 Jun 12;10:957. doi: 10.3389/fonc.2020.00957. eCollection 2020.
10
How galectins have become multifunctional proteins.半乳糖凝集素如何成为多功能蛋白。
Histol Histopathol. 2020 Jun;35(6):509-539. doi: 10.14670/HH-18-199. Epub 2020 Jan 10.